• 2',7'-Dichlorofluorescein diacetate for ROS Assays

  2026-09-09

  Use 2',7'-Dichlorofluorescein diacetate to quantify broad intracellular oxidative stress across microscopy, flow cytometry, and plate-based workflows. This guide also shows how to interpret the probe alongside redox-responsive nanocarrier studies without mistaking a general ROS signal for proof of one molecular species.

• Ciprofloxacin Hydrochloride: Single-Cell Strategy

  2026-09-09

  Ciprofloxacin hydrochloride is more than a reference fluoroquinolone antibiotic: its DNA-damaging activity, context-dependent combination behavior, and model-specific host effects make it a valuable translational research tool. This article connects single-cell evidence with assay design, clinical relevance, and strategic decision-making.

• ST3GAL1, Sialylation, and F. nucleatum in CRC

  2026-09-08

  The reference study identifies ST3GAL1-dependent sialylation as a host-cell determinant of Fusobacterium nucleatum adhesion to colorectal cancer cells. It further connects bacterial persistence and tumor-promoting activity with an H3K27ac/ANGPTL4 axis, linking surface glycan biology to intratumoral colonization.

• 2',7'-Dichlorofluorescein Diacetate for ROS

  2026-09-08

  2',7'-Dichlorofluorescein diacetate is a cell-permeable fluorogenic probe for intracellular ROS measurement and broad oxidative stress assays. Its fluorescent product reports aggregate oxidation rather than a single reactive species, so meaningful interpretation requires matched controls and orthogonal validation.

• Maternal Deltamethrin Exposure and p53-Linked Ferroptosis

  2026-09-07

  This study links maternal deltamethrin exposure with impaired hippocampal learning and memory in male offspring through p53-associated ferroptosis. Its combination of behavioral testing, neuronal staining, biochemical profiling, and pharmacological intervention provides a mechanistic framework for studying environmental neurotoxicity and calcium-homeostasis disruption.

• Batimastat (BB-94): Assay Design Guide

  2026-09-07

  A scenario-based guide to using Batimastat (BB-94), SKU A2577, in MMP inhibition, viability, tumor, and neuromuscular research. It connects biochemical potency, formulation, controls, and interpretation to practical laboratory decisions.

• 2',7'-Dichlorofluorescein Diacetate in Oncology

  2026-09-05

  A translational guide to using 2',7'-Dichlorofluorescein diacetate as a broad intracellular redox reporter in cancer biology and ROS-responsive nanomedicine, with practical assay guidance, interpretation limits, and strategic context from self-adaptive pancreatic cancer nanocarriers.

• 6-FAM SE Workflows for Durable Molecular Labeling

  2026-09-04

  6-FAM SE enables stable, amine-directed labeling of proteins, peptides, and amino-functionalized nucleic acids for sequencing, conjugation quality control, and nanoparticle tracking. This practical guide connects robust fluorescent chemistry with assay design inspired by a glutathione-responsive melanoma nanomedicine study.

• Ac-YVAD-CMK in Kupffer Cell Inflammation Assays

  2026-09-04

  Ac-YVAD-CMK provides a time-controlled way to test whether caspase-1 activity contributes to pyroptosis, cytokine release, and liver injury in Kupffer cell models. This workflow connects chemical pathway inhibition with the TMEM16F membrane-repair findings reported in Listeria monocytogenes research while emphasizing controls that distinguish reduced inflammation from impaired host defense.

• Jasplakinolide: Actin Polymerization Inducer

  2026-09-03

  Jasplakinolide is a membrane-permeable actin polymerization inducer that also stabilizes pre-existing F-actin. Its approximately 15 nM affinity in purified actin assays makes it a useful actin cytoskeleton research tool, while its fungicidal and antiproliferative activities require context-specific controls.

• In Vitro Drug Responses: Growth Inhibition vs Cell Death

  2026-09-03

  The dissertation by Hannah R. Schwartz separates relative viability from fractional viability to clarify how anticancer drugs combine proliferative arrest and cell killing. Its central finding is that most drugs affect both processes, but in different proportions and with different timing, making endpoint selection essential for interpreting in vitro drug responses.

• Dovitinib (TKI-258) RTK Signaling Workflows

  2026-09-02

  Dovitinib (TKI-258) provides a practical perturbation tool for mapping convergent RTK signaling, apoptosis induction, and treatment-response phenotypes across cancer models. This workflow connects its broad kinase coverage with the reference study’s ERK-centered melanoma findings while emphasizing controls that distinguish pathway inhibition from nonspecific cytotoxicity.

• Palonosetron Hydrochloride in Cell Assays

  2026-09-02

  This scenario-driven guide explains how Palonosetron hydrochloride (SKU B2229) can support selective 5-HT3 receptor studies, transporter inhibition experiments, and better interpretation of cell viability data. It connects quantitative assay ranges with practical preparation, controls, and evidence-based product-selection criteria.

• Cyanin Chloride in a HaCaT Psoriasis Model

  2026-09-01

  A 2024 study connected cyanin chloride treatment with reduced inflammatory signaling and improved barrier function in cytokine-stimulated HaCaT keratinocytes. Its value lies in combining antioxidant assays, macrophage inflammation testing, STAT3 analysis, cytokine profiling, TEER, and filaggrin measurements rather than relying on a single molecular endpoint.

• Streptavidin – FITC for Reliable Cell Assays

  2026-09-01

  Learn how Streptavidin – FITC (SKU K1081) supports biotin-based fluorescence readouts in cell viability, proliferation, cytotoxicity, imaging, and flow cytometry workflows. This scenario-driven guide explains assay design, spectral compatibility, protocol controls, interpretation limits, and practical vendor-selection criteria.

7784 records 1/519 page Next 12345 下5页 Last page